Marizyme
(OTC) MRZM
Marizyme Financials at a Glance
Market Cap
$100
Revenue (TTM)
$183.42K
Net Income (TTM)
$22.02M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-5.85 (Low)
Dividend
$0.00
Beta (Volatility)
-5.85 (Low)
Price
$0.00
Volume
92
Open
$0.00
Price
$0.00
Volume
92
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-5.85 (Low)
Price
$0.00
Volume
92
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
MRZM News
MRZM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Marizyme
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
David L. Barthel, MBA
Website
www.marizyme.comHeadquarters
Jupiter, FL 33458, US
MRZM Financials
Key Financial Metrics (TTM)
Gross Margin
37%
Operating Margin
-53%
Net Income Margin
-108%
Return on Equity
0%
Return on Capital
54%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.00
Shares Outstanding
131.79M
Volume
92
Short Interest
0.00%
Avg. Volume
1.533
Financials (TTM)
Gross Profit
$238.91K
Operating Income
$34.09M
EBITDA
$55.44M
Operating Cash Flow
$4.68M
Capital Expenditure
$0.00
Free Cash Flow
$4.68M
Cash & ST Invst.
$148.47K
Total Debt
$20.76M
Marizyme Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$210.78K
-261.5%
Gross Margin
0.00%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$7.69
N/A
Employees
13
N/A
Net Income
$1.96M
+94.0%
EBITDA
$644.00K
+97.4%
Quarterly Fundamentals
Net Cash
$26.59M
-25.9%
Accounts Receivable
$37.88K
-52.0%
Inventory
$26.87K
-72.9%
Long Term Debt
$355.18K
-55.9%
Short Term Debt
$26.30M
+26.5%
Return on Assets
-3.16%
N/A
Return on Invested Capital
54.31%
N/A
Free Cash Flow
$983.13K
+14.7%
Operating Cash Flow
$983.13K
+14.7%